United Health Products updates on FDA PMA process and Triton Funds investment

United Health Products, Inc.

FDA requested details on HemoStyp manufacturing process; UHP implemented GMP software tool and will respond later this month.
SEC declared UHP's registration statement effective on September 29, allowing closure of $4M-$6M stock purchase with Triton Funds.
UHP produced a prototype of new HemoStyp format for trauma/surgical applications; further testing planned.
Company will host investor information session on October 15, 2021 at 9am ET.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.